Navigation Links
Novavax Reports Second Quarter 2009 Financial Results
Date:8/7/2009

General and administrative costs were $2.6 million in the second quarter of 2009 as compared to $3.2 million in the second quarter of 2008. The decrease of 19% was due to a reduction in employee costs of $0.2 million, a decrease in facility costs associated with general and administrative functions of $0.1 million, and a $0.1 million decrease in charges to the allowance established for two notes receivable from former directors. The balance of the decrease is attributable to a decrease in professional fees.

Novavax recorded net interest and other expense of $0.7 million for the second quarter of 2009 compared to net interest and other expense of $0.1 million for the second quarter of 2008. The increase in net interest and other expense primarily resulted from an additional other than temporary impairment in the amount of $0.5 million related to one of the company's auction rate securities due primarily to its continued illiquidity and a $0.2 million decrease in interest income due to a decrease in the average cash and short-term investments balance during the quarter.

Accordingly, Novavax's net loss for the quarter ended June 30, 2009 was $8.5 million, or $0.10 per share, compared to a net loss of $9.4 million, or $0.15 per share, for the quarter ended June 30, 2008. The loss for the quarter ended June 30, 2008 includes a loss from discontinued operations of $1.1 million.

As of June 30, 2009, Novavax had $31.2 million in cash and short-term investments (including auction rate securities recorded at their fair value) as compared to $33.9 million as of December 31, 2008. The company's short-term investments consist of investments in five auction rate securities with a par value of $8.1 million and a fair value of $6.0 million. In addition to the other than temporary impairment discussed above, during the second quarter of 2009, the company recorded a $0.5 million unrealized gain, which is included in
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
2. Novavax Announces Release Date of 2009 Second Quarter, Financial Results and Investor Conference Call
3. Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies
4. Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
5. Novavax Announces Repayment of $5 Million of Convertible Debt
6. Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
7. Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain
8. Novavax Appoints Stanley Erck to Board of Directors
9. Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine
10. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2009
11. Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Shimadzu Corporation announced that its ... system (Nexera UC) received the Pittcon Editors’ Gold ... Chemistry and Applied Spectroscopy (Pittcon) held in New ... , The Pittcon Editors’ Awards recognize the most ... time based on votes by the media corps. ...
(Date:4/1/2015)... -- ValGenesis Inc., the market leader in enterprise Validation Lifecycle ... its Service Organization Controls 2 (SOC 2) examination under ... the period of January 1 st  2014  through ... Logo - http://photos.prnewswire.com/prnh/20150401/195954LOGO ... The SOC 2 examination is performed in accordance with ...
(Date:4/1/2015)... Proove Biosciences , a commercial ... two scientific posters at the Annual Clinical Genetics Meeting ... event was hosted at the Salt Palace Convention Center ... genetic and genomic professionals on breakthrough advances in clinical ... on the Role of DAT1 in Risk of Insomnia ...
(Date:4/1/2015)... 1, 2015  Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, presented data on ... the 2015 Experimental Biology conference in ... represents an ideal extension of Organovo,s capabilities to ... useful in pharmaceutical research," said Keith Murphy ...
Breaking Biology Technology:Shimadzu Nexera UC Recognized at Pittcon 2015 with Editors’ Gold Award 2ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 2ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 3Proove Biosciences Presents Research Studies at Annual Clinical Genetics Meeting 2015 2Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 2Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 3Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 4
... Claire, Wis. A team of Chippewa Valley representatives hope ... Twin Cities this week at the largest medical device ... & Manufacturing tradeshow at the Minneapolis Convention Center on ... 7,000 medical equipment and pharmaceutical company executives. , ,The ...
... The SBC Foundation , the philanthropic ... in SBC Excelerator technology grants to eight local nonprofit ... Excelerator is a major philanthropic initiative that connects the ... families, to important community resources. The program also empowers ...
... City Mayor Rudolph Giuliani will keynote RedShift 2006 ... and logistics industry summit at the Westin La Paloma ... , ,Giuliani will discuss how leaders at all ... corporate and organizational cultures. , ,RedPrairie provides industry-tailored supply-chain ...
Cached Biology Technology:Chippewa Valley reps hope to score at Twin Cities tradeshow 2SBC foundation gives Excelerator grants to local nonprofits 2SBC foundation gives Excelerator grants to local nonprofits 3SBC foundation gives Excelerator grants to local nonprofits 4
(Date:3/17/2015)... , March 17, 2015 MedNet ... specializing in clinical study management systems, is pleased ... attendance at ARENA,s Outsourcing in Clinical Trials Southeast ... event provides an excellent forum for MedNet to ... and affordable software-as-a-service (SaaS) eClinical technology platform. ...
(Date:3/12/2015)... 12, 2015 IriTech, a leading iris based ... the Texas Instruments Design Network, announced today that the ... its IriShield USB MK2120U device during a launching event ... distribution. The iris scanner is manufactured ... in India through its Indian ...
(Date:3/11/2015)... Research and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ) ... Market by Product, Application & By Geography - Global ... offering. , This report predicts that the ... by 2020, with an estimated CAGR of 10.6%. ... types such as contact cards & readers, contactless cards ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2
... Worcester, Mass. Development of new therapies for ... heart attackswill be supported by a new production-scale microthread ... students and biomedical engineering faculty at Worcester Polytechnic Institute ... the final stages of testing and validation, and will ...
... , Ottawa, Ontario (April 30, 2012) In a ... and Aquatic Sciences, biologist Douglas Swain of the Gulf Fisheries ... of Oceanography present findings that suggest the delay in recovery ... attributed to increased predation by grey seals or other governing ...
... less weight more times is just as effective at building ... researchers that turns conventional wisdom on its head. The ... the point of fatigue. "We found that loads ... at inducing muscle growth and promoting strength," says Cam Mitchell, ...
Cached Biology News:WPI team scales-up production of biopolymer microthreads 2WPI team scales-up production of biopolymer microthreads 3WPI team scales-up production of biopolymer microthreads 4Light weights are just as good for building muscle, getting stronger, researchers find 2
Recommended for supporting the growth of anchorage-dependent cells including human and mouse stromal cells, mesenchymal cells and cell lines....
ID clarifier: With ethidium bromide (50 μg/ml)...
... is a fluorescent nucleic acid dye which ... As a nuclear counterstain, propidium iodide stains ... color. The fluorescent red color provides ... such as FITC, Cy2 or AMCA. ...
... Mouse EL-4 cells were cultured in DMEM ... In order to keep the antigens in ... The cells are arrayed on a 12-well ... surface specifically treated to enhance cellular attachment and ...
Biology Products: